{"schema":"hottub-news/story/v1","story":"st_psitonzhfxu7qknafg4a","title":"鉅亨速報 - Factset 最新調查：默克藥廠MRK-US的目標價調升至160元，幅度約3.23%","title_en":"Factset's latest survey: Merck's target price raised to 160, up about 3.23%","outlets":1,"brief":null,"page":"https://hottub.news/stories/factsets-latest-survey-mercks-target-price-raised-to-160-up-about-3-23-psitonzhfx","count":1,"items":[{"id":"n_psitonzhfxu7qknafg4a","seq":669745,"kind":"article","title":"鉅亨速報 - Factset 最新調查：默克藥廠MRK-US的目標價調升至160元，幅度約3.23%","title_en":"Factset's latest survey: Merck's target price raised to 160, up about 3.23%","url":"https://news.cnyes.com/news/id/6618087","summary":"根據FactSet最新調查，共25位分析師，對默克藥廠(MRK-US)提出目標價估值：中位數由155元上修至160元，調升幅度3.23%。其中最高估值186元，最低估值105元。綜合評級 - 共有31位分析師給予默克藥廠評價：積極樂觀21位、保持中立9位、保守悲觀1位。默克藥廠今(29日)收盤價為1","published":"2026-09-29T12:15:25Z","seen":"2026-09-29T12:40:50Z","lang":"zh","country":"TW","source":{"id":"kite-news-cnyes-com-887ba2","name":"news.cnyes.com","domain":"news.cnyes.com"},"via":"kite-news-cnyes-com-887ba2","topics":["美股預估"],"authors":["鉅亨網新聞中心"],"entities":[{"id":"Q96472579","name":"Merck","type":"org"}],"image":"https://cimg.cnyes.cool/static/rss/default/m/02.jpg","story":"st_psitonzhfxu7qknafg4a","category":"economy-business","category_p":0.8299999833106995,"sentiment":"neutral","tone":0.10999999940395355,"political":0.03999999910593033}]}